rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-10-2
|
pubmed:abstractText |
Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1973-9
|
pubmed:meshHeading |
pubmed-meshheading:16881100-Adult,
pubmed-meshheading:16881100-Aged,
pubmed-meshheading:16881100-Antirheumatic Agents,
pubmed-meshheading:16881100-Arachidonic Acid,
pubmed-meshheading:16881100-Arthritis, Rheumatoid,
pubmed-meshheading:16881100-Cardiovascular Diseases,
pubmed-meshheading:16881100-Dietary Supplements,
pubmed-meshheading:16881100-Dinoprostone,
pubmed-meshheading:16881100-Dose-Response Relationship, Drug,
pubmed-meshheading:16881100-Drug Therapy, Combination,
pubmed-meshheading:16881100-Eicosanoids,
pubmed-meshheading:16881100-Female,
pubmed-meshheading:16881100-Fish Oils,
pubmed-meshheading:16881100-Humans,
pubmed-meshheading:16881100-Hydroxychloroquine,
pubmed-meshheading:16881100-Male,
pubmed-meshheading:16881100-Methotrexate,
pubmed-meshheading:16881100-Middle Aged,
pubmed-meshheading:16881100-Risk Factors,
pubmed-meshheading:16881100-Sulfasalazine,
pubmed-meshheading:16881100-Thromboxane A2
|
pubmed:year |
2006
|
pubmed:articleTitle |
Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
|
pubmed:affiliation |
Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, Australia. lcleland@mail.rah.sa.gov.au
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|